Page last updated: 2024-08-21

quinazolines and caffeine

quinazolines has been researched along with caffeine in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19902 (7.41)18.7374
1990's7 (25.93)18.2507
2000's12 (44.44)29.6817
2010's5 (18.52)24.3611
2020's1 (3.70)2.80

Authors

AuthorsStudies
Hill, RC; van Graffenried, B1
Adén, U; Fredholm, BB; Johansson, B; Lindström, K; Svenningsson, P1
Holtzman, SG1
Adolphe, M; Cheymol, J; Deysson, G1
Howell, LL1
Byrd, LD; Howell, LL1
Fredholm, BB; Johansson, B; Kuzmin, A; Zvartau, EE1
Fredholm, BB; Lindström, K1
Borgeat, P; Bourgoin, SG; Harbour, D; Naccache, PH; Thibault, N1
Gean, PW; Lu, KT; Wu, SP1
Hamann, M; Richter, A1
Bamburg, JR; Bedford, JS; Bernstein, BW; Jha, MN1
Anderson, KE; Daniele, N; Foukas, LC; Jensen, J; Ktori, C; Shepherd, PR1
O'Regan, MH; Phillis, JW1
Bremer, HC; Elsner, P; Girolomoni, G; Herouy, Y; Idzko, M; Mockenhaupt, M; Norgauer, J; Panther, E; Sorichter, S; Windisch, W1
Bennett, MR; Lin, YQ1
Chang, CH; Lin, LC; Tsai, TH1
Holý, A; Kmonícková, E; Potmesil, P; Zídek, Z1
Holý, A; Kmonícková, E; Krecmerová, M; Potmesil, P; Zídek, Z1
Beamish, H; Chau, YQ; Gabrielli, B; Giles, N; Harding, A; Stevens, F1
Ahlawat, R; Chavez-Valdez, R; Cristofalo, EA; Gauda, EB; Nathan, A; Wills-Karp, M1
Bista, SR; Jahng, Y; Jeong, TC; Kang, MJ; Kang, W; Kim, E; Lee, SK; Noh, K; Seo, YM1
Datino, T; Fernández-Avilés, F; Figueiras-Graillet, L; Franklin, R; Gama, JG; Jones, C; Martínez-Sellés, M1
Edling, CE; Falasca, M; Ghonaim, R; Maffucci, T; Selvaggi, F1
Mallick, S; Pattnaik, S; Rao, JV; Swain, K; Varun, T1
Ishikawa, T; Nakamura, M; Nishiyama, R; Saito, SY; Todoroki, K; Toyo'oka, T; Yamaguchi, M1
Brenner, DJ; Cunha, L; Garty, G; Harken, A; Perrier, JR; Pujol-Canadell, M; Shuryak, I1

Trials

2 trial(s) available for quinazolines and caffeine

ArticleYear
Headache as a model for testing mild analgesics.
    Research and clinical studies in headache, 1978, Volume: 6

    Topics: Adult; Aminopyrine; Analgesics; Antipyrine; Aspirin; Barbiturates; Caffeine; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Headache; Humans; Male; Placebos; Quinazolines

1978
Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.
    Clinical drug investigation, 2013, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Area Under Curve; Arrhythmias, Cardiac; Biotransformation; Caffeine; Chi-Square Distribution; Cross-Over Studies; Cytochrome P-450 CYP1A2; Drug Interactions; Electrocardiography; Fasting; Female; Food-Drug Interactions; Half-Life; Headache; Heart Rate; Hematologic Agents; Humans; Hydroxylation; Intestinal Absorption; London; Male; Metabolic Clearance Rate; Postprandial Period; Quinazolines; Young Adult

2013

Other Studies

25 other study(ies) available for quinazolines and caffeine

ArticleYear
Evidence that the increase in striatal c-fos following acute high-dose caffeine is not due to direct interaction with striatal adenosine receptors.
    Acta physiologica Scandinavica, 1992, Volume: 146, Issue:4

    Topics: Adenosine; Animals; Caffeine; Corpus Striatum; Dose-Response Relationship, Drug; Genes, fos; Purinergic Antagonists; Quinazolines; Rats; RNA, Messenger; Triazoles; Xanthines

1992
CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.
    Life sciences, 1991, Volume: 49, Issue:21

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Dose-Response Relationship, Drug; Drug Tolerance; Male; Motor Activity; Quinazolines; Rats; Rats, Inbred Strains; Triazoles

1991
[Comparative study of the action of some cytodieresis inhibitors on plant cells and on animal cells].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1967, Jul-20, Volume: 161, Issue:2

    Topics: Caffeine; Mitosis; Plant Cells; Plants; Quinazolines

1967
Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Behavior, Animal; Caffeine; Carbon Dioxide; Conditioning, Psychological; Female; Macaca mulatta; Male; Phosphodiesterase Inhibitors; Quinazolines; Respiration; Triazoles

1993
Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1

    Topics: Animals; Behavior, Animal; Caffeine; Drug Interactions; Drug Synergism; Male; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Quinazolines; Receptors, Purinergic P1; Rolipram; Saimiri; Time Factors; Triazoles

1993
Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Animals; Behavior, Animal; Caffeine; Cocaine; Extinction, Psychological; Male; Mice; Mice, Inbred DBA; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Reward; Substance Abuse, Intravenous; Theophylline; Triazoles; Xanthines

1999
Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
    European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3

    Topics: Adenosine; Animals; Autoradiography; Binding, Competitive; Brain; Caffeine; In Vitro Techniques; Male; Phenethylamines; Purinergic P1 Receptor Antagonists; Pyrazines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles; Tritium; Xanthines

1999
Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases.
    Blood, 2000, Jan-15, Volume: 95, Issue:2

    Topics: Adenosine; Adenosine Deaminase; Adenosine-5'-(N-ethylcarboxamide); ADP-Ribosylation Factor 1; Adult; Caffeine; Cell Membrane; Enzyme Activation; GTP Phosphohydrolases; Humans; In Vitro Techniques; Isoenzymes; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenethylamines; Phospholipase D; Protein Kinase C; Protein Kinase C-alpha; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Purinergic P1; rhoA GTP-Binding Protein; Triazoles

2000
Promotion of forskolin-induced long-term potentiation of synaptic transmission by caffeine in area CA1 of the rat hippocampus.
    The Chinese journal of physiology, 1999, Dec-31, Volume: 42, Issue:4

    Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Central Nervous System Stimulants; Colforsin; Cyclic AMP; Drug Synergism; Excitatory Postsynaptic Potentials; Hippocampus; Long-Term Potentiation; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Triazoles; Xanthines

1999
Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Adenosine; Animals; Caffeine; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Female; Male; Mesocricetus; Muscle Contraction; Mutation; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Theobromine; Theophylline; Triazines; Triazoles; Xanthines

2001
Caffeine eliminates gamma-ray-induced G2-phase delay in human tumor cells but not in normal cells.
    Radiation research, 2002, Volume: 157, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Breast Neoplasms; Caffeine; Calcium Channel Blockers; Calcium Signaling; Carcinoma; Chickens; Demecolcine; Drug Resistance; Female; Fibroblasts; G2 Phase; Gamma Rays; HeLa Cells; Humans; Mitosis; Neoplastic Stem Cells; Neurons; Ovarian Neoplasms; Phosphodiesterase Inhibitors; Quinazolines; Radiation Tolerance; Ryanodine; Ryanodine Receptor Calcium Release Channel; Thapsigargin; Tumor Cells, Cultured

2002
Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities.
    The Journal of biological chemistry, 2002, Oct-04, Volume: 277, Issue:40

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Transport; Caffeine; CHO Cells; Cricetinae; Deoxyglucose; Dimerization; Flavins; Glucose; Kinetics; Monosaccharide Transport Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Quinazolines; Recombinant Fusion Proteins; Theophylline; Transfection; Triazoles

2002
Effects of adenosine receptor antagonists on pial arteriolar dilation during carbon dioxide inhalation.
    European journal of pharmacology, 2003, Aug-29, Volume: 476, Issue:3

    Topics: Adenosine; Administration, Inhalation; Animals; Caffeine; Carbon Dioxide; Cerebral Cortex; Cerebral Veins; Cerebrovascular Circulation; Drug Interactions; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Sprague-Dawley; Triazines; Triazoles; Vasodilation; Vasodilator Agents; Xanthines

2003
Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature human dendritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors.
    Journal of cellular physiology, 2004, Volume: 199, Issue:1

    Topics: Actins; Antigens, CD; Caffeine; Calcium; Cell Differentiation; Chemotaxis; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Flow Cytometry; Histocompatibility Antigens Class I; Humans; Inosine; Pertussis Toxin; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Triazoles; Xanthines

2004
Varicosity-Schwann cell interactions mediated by ATP in the mouse vas deferens.
    Journal of neurophysiology, 2005, Volume: 93, Issue:5

    Topics: Adenosine Triphosphate; Adrenergic Fibers; Aniline Compounds; Animals; Caffeine; Calcium; Cell Count; Drug Interactions; Electric Stimulation; Estrenes; Evoked Potentials; Fluorescent Dyes; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Organic Chemicals; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Pyrrolidinones; Quinazolines; S100 Proteins; Schwann Cells; Suramin; Time Factors; Triazoles; Uridine Triphosphate; Vas Deferens; Xanthenes

2005
Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.
    Planta medica, 2005, Volume: 71, Issue:7

    Topics: Administration, Oral; Alkaloids; Animals; Area Under Curve; Bile; Brain; Caffeine; Drug Interactions; Drugs, Chinese Herbal; Evodia; Indole Alkaloids; Infusions, Intravenous; Male; Phytotherapy; Plant Extracts; Quinazolines; Quinolines; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Vasodilator Agents

2005
Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 2-Aminopurine; Adenine; Adjuvants, Immunologic; Animals; Anti-HIV Agents; Caffeine; Cell Survival; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Dihydropyridines; Dose-Response Relationship, Drug; Female; Flavins; Humans; Interleukin-10; Lipopolysaccharides; Macrophage Inflammatory Proteins; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Organophosphonates; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Triazoles; Tumor Necrosis Factor-alpha

2006
Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives.
    European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3

    Topics: Adenine; Animals; Caffeine; Cell Survival; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Female; Gene Expression; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleotides; Organophosphonates; Organophosphorus Compounds; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles

2006
Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells.
    The Journal of biological chemistry, 2007, Mar-09, Volume: 282, Issue:10

    Topics: Apoptosis; Benzamides; Caffeine; Cell Line; G2 Phase; Humans; Mitosis; p21-Activated Kinases; Protein Serine-Threonine Kinases; Quinazolines; Spindle Apparatus

2007
Caffeine modulates TNF-alpha production by cord blood monocytes: the role of adenosine receptors.
    Pediatric research, 2009, Volume: 65, Issue:2

    Topics: Acetamides; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Adult; Blotting, Western; Caffeine; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fetal Blood; Humans; Infant, Newborn; Interleukins; Lipopolysaccharides; Middle Aged; Monocytes; Purines; Quinazolines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Triazines; Triazoles; Tumor Necrosis Factor-alpha; Xanthines

2009
Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
    Archives of pharmacal research, 2011, Volume: 34, Issue:1

    Topics: Administration, Oral; Animals; Area Under Curve; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Drug Interactions; Enzyme Induction; Indole Alkaloids; Quinazolines; Rats; Rats, Sprague-Dawley; Theobromine; Theophylline; Vasodilator Agents

2011
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.
    Cancer biology & therapy, 2014, Volume: 15, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Caffeine; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Quinazolines; Signal Transduction; Triazoles

2014
Temperature influencing permeation pattern of alfuzosin: an investigation using DoE.
    Medicina (Kaunas, Lithuania), 2015, Volume: 51, Issue:4

    Topics: Absorption, Physicochemical; Administration, Cutaneous; Adrenergic alpha-1 Receptor Antagonists; Cadaver; Caffeine; Cellulose; Epidermis; Hot Temperature; Humans; Membranes, Artificial; Parabens; Permeability; Pharmaceutical Vehicles; Quinazolines; Solubility; Urological Agents

2015
Caffeine Suppresses the Activation of Hepatic Stellate Cells cAMP-Independently by Antagonizing Adenosine Receptors.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:5

    Topics: Animals; Caffeine; Cells, Cultured; Chelating Agents; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Hepatic Stellate Cells; Liver Cirrhosis; Male; MAP Kinase Signaling System; Mice; Phosphodiesterase Inhibitors; Phosphorylation; Quinazolines; Receptors, Purinergic P1; Triazoles

2017
Cytogenetically-based biodosimetry after high doses of radiation.
    PloS one, 2020, Volume: 15, Issue:4

    Topics: Adult; Benzamides; Caffeine; Cells, Cultured; Cytogenetics; Dose-Response Relationship, Radiation; Female; Humans; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Neutrons; Protons; Quinazolines; Radiation Dosage; Radiometry

2020